Trial
NCT04440488
ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Shire
Collaborators
—
Condition
Chronic Obstructive Pulmonary Disease
Intervention
ARALAST NP
Why stopped
Reevaluation of development strategy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-14